Splitting single-use drug vials among patients is clinical, coding no-no

Why This Topic Matters

The topic affects claim accuracy, compliance risk, and how drug wastage is reported when single-use vials are used in patient care. It also highlights that payer-specific billing procedures can differ, making policy awareness important for practices submitting drug administration claims.

Article Sections

1. Billing

   Introduces the compliance issue and the general billing context for single-use drug and biological vials. It frames the discussion around Medicare overbilling allegations and related federal guidance.

2. How to bill single-use vials

   Summarizes the article’s discussion of drug billing and wastage reporting using a specific drug example. It also references payer and Medicare policy considerations for single-use vial claims.

3. Example and payer policy differences

   Presents a worked example involving infused drug administration and then describes how different payers may handle discarded drug reporting. It compares general approaches used by Medicare contractors and other payers.

4. Online sources

   Lists external reference materials and policy resources cited in the article. These sources include federal guidance and payer publications related to drug wastage and injection safety.